Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029463 (
osteosarcoma
)
16,637
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Necdin
is a nuclear protein expressed in virtually all postmitotic neurons, and ectopic expression of this protein strongly suppresses the proliferation of NIH3T3 cells. Simian virus 40 large T antigen targets both p53 and the retinoblastoma protein (Rb) for cellular transformation. By analogy with the interactions of the large T antigen with these nuclear growth suppressors, we examined the ability of
necdin
to bind to the large T antigen.
Necdin
was co-immunoprecipitated with the large T antigen from the nuclear extract of
necdin
cDNA-transfected COS-1 cells. Yeast two-hybrid and in vitro binding analyses revealed that
necdin
bound to an amino-terminal region of the large T antigen, which encompasses the Rb-binding domain. Moreover,
necdin
bound to adenovirus E1A, another viral oncoprotein that forms a specific complex with Rb. We then examined the ability of
necdin
to bind to the transcription factor E2F1, a cellular Rb-binding factor involved in cell-cycle progression. Intriguingly,
necdin
, like Rb, bound to a carboxyl-terminal domain of E2F1, and repressed E2F-dependent transactivation in vivo. In addition,
necdin
suppressed the colony formation of Rb-deficient SAOS-2
osteosarcoma
cells. These results suggest that
necdin
is a postmitotic neuron-specific growth suppressor that is functionally similar to Rb.
...
PMID:Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. 942 23
Necdin
is expressed in virtually all postmitotic neurons, and ectopic expression of this protein suppresses cell proliferation.
Necdin
, like the retinoblastoma protein, interacts with cell cycle promoting proteins such as simian virus 40 large T antigen, adenovirus E1A, and the transcription factor E2F1. Here we demonstrate that
necdin
interacts with the tumor suppressor protein p53 as well. The yeast two-hybrid and in vitro binding analyses revealed that
necdin
bound to a narrow region (amino acids 35-62) located between the MDM2-binding site and the proline-rich region in the amino-terminal domain of p53. The electrophoretic mobility shift assay showed that
necdin
supershifted a complex between p53 and its binding DNA, implying that the p53-
necdin
complex is competent for DNA binding. In p53-deficient
osteosarcoma
SAOS-2 cells,
necdin
markedly suppressed p53-dependent activation of the p21/WAF promoter.
Necdin
and p53 inhibited cell growth in an additive manner as assessed by the colony formation of SAOS-2 cells, suggesting that
necdin
does not affect p53-mediated growth suppression. On the other hand,
necdin
inhibited p53-induced apoptosis of
osteosarcoma
U2OS cells. Thus,
necdin
can be a growth suppressor that targets p53 and modulates its biological functions in postmitotic neurons.
...
PMID:Physical and functional interactions of neuronal growth suppressor necdin with p53. 1034 80
Necdin
is a growth suppressor expressed predominantly in postmitotic neurons. The
necdin
gene is involved in the etiology of the genomic imprinting-associated neurodevelopmental disorder Prader-Willi syndrome and belongs to the MAGE gene family. All the MAGE family proteins contain a large homology domain termed the MAGE homology domain (MHD). We here characterize the regions of
necdin
required for the protein-protein interaction, nuclear matrix targeting, and cell growth suppression. The region including entire MHD (amino acids 116-280) of
necdin
was required for its interaction with p53, while the regions amino acids 144-184 and 191-222 within the MHD were required for both the nuclear matrix targeting and the cell growth suppression of
osteosarcoma
SAOS-2 cells. The amino-terminal proline-rich acidic region (amino acids 60-100) was also necessary for cell growth suppression. Tetracycline-regulatable overexpression of
necdin
induced growth arrest of SAOS-2 cells in a reversible manner, and the
necdin
-overexpressing cells showed a large, flattened morphology with double nuclei. In contrast, a
necdin
mutant lacking amino acids 191-222 did not induce such changes. These findings suggest that different functions of
necdin
are mediated via its distinct domains.
...
PMID:Functional domains of necdin for protein-protein interaction, nuclear matrix targeting, and cell growth suppression. 1557 80
Genomic imprinting, a heritable form of epigenetic information, is thought to play an important role in tumor progression. DNA methylation is a common mechanism of genomic imprinting. To evaluate the genome-wide effects of malignant transformation on
osteosarcoma
progression, we examined multiple biological properties, including DNA methylation, in human osteoblast hFOB1.19 cells (ATCC Catalog No. CRL-11372) transformed by treatment with carcinogenic agent N-Methyl-N'-nitro-N-nitrosoguanidine (MNNG, 1.0 microg/ml) and carcinogenic promoting agent 12-O-tetradecanoyl phorbol-13-acetate (TPA, 200 ng/ml). We also examined global changes in expression of imprinted genes during transformation using microarray analysis. Ten imprinted genes, including H19, MKRN3,
NDN
, CDKN1C, PHLDA2, MEST, CD81, GRB10, SLC22A18, and SLC22A3 were aberrantly regulated in transformed cells, suggesting roles in tumorigenesis. Moreover, we analyzed the methylation state of the promoter regions of H19, PHLDA2, and SLC22A18 genes by bisulfite sequencing array and observed a correlation between upregulated expression of H19 and PHLDA2 genes and hypomethylation of their promoter regions, although this was not observed for SLC22A18. Our results suggest that changes in expression of imprinted genes caused by changes in methylation are involved, and are among the earliest events, in neoplastic progression.
...
PMID:Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma. 1850 91